The results of a recent study reveal that the severity of respiratory infections depends at least in part on a complex interplay between the gut microbiota and the immune system.
Researchers at the San Gallicano Dermatological Institute in Rome, Italy, conducted an open-label exploratory trial to assess the therapeutic potential of EUTOPLAC, a topical probiotic containing Lactobacillus crispatus P 17631…
Aran Singanayagam, research group leader at Imperial College London (UK), examined how disturbances in the airway microbiome are instrumental in the development of chronic lung diseases.
The results of a recent study shed light on the effects of aspirin use on the gut microbiota. The findings may also inform therapies for aspirin-mediated gastrointestinal damage.
The findings of a recent study shed light on the role of complement proteins in breast milk and provide a mechanism through which breastfeeding may provide protection from certain bacterial…
Launching a new frontier in IBS management: the 'TrIuMPH' trial sets the stage with EBX-102-02, a pioneer in microbiome-based therapy.
An exclusive interview with Daniel Brownell, Senior Director of Research & Development at AOBiome Therapeutics, whose core technology is ammonia oxidizing bacteria, formulated as a topical suspension of bacteria applied…
The findings of a recent study suggest that antimicrobial-resistance mutations in commensal bacteria can make the microbiota surprisingly resilient to antibiotics.
The findings of a recent study suggest that the gut microbiota contributes to alterations in the levels of metabolites associated with ulcerative colitis.
Antonio Gomes, Principal Scientist at Xbiome, talks about employing deep learning techniques to refine the prediction of natural product structures directly from gene sets.
